Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Net Margin
Changzhou Qianhong Biopharma Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 7.4B CNY |
| Net Margin |
12%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 744.3B USD |
| Net Margin |
17%
|
| Country | DK |
| Market Cap | 4.1T DKK |
| Net Margin |
37%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | US |
| Market Cap | 364.1B USD |
| Net Margin |
45%
|
| Country | US |
| Market Cap | 331.8B USD |
| Net Margin |
4%
|
| Country | UK |
| Market Cap | 189.2B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 188.1B CHF |
| Net Margin |
20%
|
| Country | CH |
| Market Cap | 182.7B CHF |
| Net Margin |
30%
|
| Country | US |
| Market Cap | 161.7B USD |
| Net Margin |
-1%
|
Profitability Report
View the profitability report to see the full profitability analysis for Changzhou Qianhong Biopharma Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Changzhou Qianhong Biopharma Co Ltd's most recent financial statements, the company has Net Margin of 12%.
You don't have any saved screeners yet
